ORION PHARMA A/S: Financial statements 2023
CVR: 20601116
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
ORION PHARMA A/S (CVR 20601116) has filed annual accounts for 2023. In 2023, the company reported revenue of DKK 253,050,082 and a net result of DKK 8,232,002 compared with DKK 7,529,338 the year before. That is an increase of 18.2% compared with the year before. The profit margin was 3.3%. Equity in the 2023 report amounted to DKK 51,685,038. The solvency ratio was 57.7%. The company had 16 employees in the financial year.
- Revenue
- DKK 253,050,082
- Gross Profit
- DKK 25,098,160
- Profit/Loss
- DKK 8,232,002
- Equity
- DKK 51,685,038
- Total Assets
- DKK 89,648,130
- Employees
- 16
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | 253.1M | 25.1M | 8.2M | 51.7M | 16 |
| 2022 | 214.2M | 24.9M | 7.5M | 50.5M | 16 |
| 2021 | 212.5M | 20.7M | 4.5M | 47.9M | 17 |
| 2020 | 282.9M | 25.5M | 6.3M | 51.4M | 20 |
| 2019 | 280.9M | 43M | 16.9M | 57.6M | 24 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
ORION PHARMA A/S has published its annual report for 2022. Revenue came to DKK 214,174,882, and the net result was DKK 7,529,338.
About ORION PHARMA A/S
ORION PHARMA A/S is a Danish company of the type Aktieselskab based in København S, founded in 1953. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named ERCOPHARM A/S. The management consists of Jesper Otto Qvist-Pedersen. The board consists of Satu Maarit Ahomäki (chair), Mikko Tapani Kemppainen and René Kristian Lindell. The company is owned by Orion Corporation. The company has 14 employees (2026). In 2025, the company reported revenue of DKK 329,561,856 and a net result of DKK 10,525,947 compared with DKK 10,899,639 the year before. Equity in the 2025 report amounted to DKK 32,510,625.